Clinical Trials Directory

Trials / Completed

CompletedNCT04689867

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1

Feasibility, Acceptability, and Preliminary Effectiveness of a Cognitive-behavioral Suicide Prevention-focused Intervention Tailored to Adults Diagnosed With Schizophrenia Spectrum Disorders: Aim 1 Open Pilot Trial to Test Modified Treatment and Measurement Prior to Aim 2 RCT (Registered Separately)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators are modifying and testing the preliminary effectiveness and implementation of a Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) intervention. In this phase of the study, CBSPp will be tested in an initial open trial (n = 10) to examine its feasibility and acceptability. Investigators will recruit clients receiving services at a community mental health setting who have a schizophrenia spectrum disorder and recent suicidal thoughts and behaviors to receive the behavioral intervention for 10-weeks. Providers will be recruited and trained to deliver the intervention. Both clients and providers will be assessed at baseline to test our approach to measurement prior to the Aim 2 RCT (registered separately). Clients will be assessed at three additional timepoints (middle of treatment, end of treatment, and 2 months after treatment ends.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavioral Suicide Prevention for psychosis CBSPp)Cognitive and behavioral approach to suicide prevention among individuals with psychosis

Timeline

Start date
2021-09-01
Primary completion
2022-04-01
Completion
2022-04-11
First posted
2020-12-30
Last updated
2023-04-24
Results posted
2023-04-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04689867. Inclusion in this directory is not an endorsement.